Barclays lowered the firm’s price target on Agilent (A) to $135 from $145 and keeps an Underweight rating on the shares following the “fine” ...

Agilent Technologies A reported fourth-quarter fiscal 2024 earnings of $1.46 per share, which beat the Zacks Consensus ...

Agilent (A – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Puneet Souda from Leerink Partners maintained a Buy rating on the stock and has ...

Evercore ISI lowered the firm’s price target on Agilent (A) to $142 from $145 and keeps an In Line rating on the shares. A “consistent print” ...

I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic ...

Throughout the last three months, 4 analysts have evaluated Agilent Technologies A +0.10% Get Free Report , offering a ...

Agilent Technologies posted lower profit in the fourth quarter despite a slight rise in its revenue. The Santa Clara, Calif.-based laboratory-supply and services company on Monday reported a profit of ...

SANTA CLARA, Calif. — SANTA CLARA, Calif. — Agilent Technologies Inc. (A) on Monday reported fiscal fourth-quarter earnings of $351 million. The Santa Clara, California-based company said it had ...

Chris Katje Why Is Agilent Up 1.2% Since Last Earnings Report? It has been about a month since the last earnings report for Agilent Technologies (NYSE: A). Shares have added about 1.2% in that ...

The ZORBAX RRHD 300-HILIC columns for glycopeptide analysis feature 1.8 µm particles and a 300Å pore size. These enable to resolve peptide glycoforms. The ZORBAX RRHD 300-HILIC columns are part ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...